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Behavioral deficits, early gliosis, dysmyelination
and synaptic dysfunction in a mouse model of
mucolipidosis IV
Yulia Grishchuk1, Sarmi Sri2, Nikita Rudinskiy3, Weiyuan Ma1, Katherine G Stember1, Matthew W Cottle1,
Ellen Sapp3, Marian Difiglia3, Alona Muzikansky4, Rebecca A Betensky4, Andrew M S Wong2, Brian J Bacskai3,
Bradley T Hyman3, Raymond J Kelleher III1, Jonathan D Cooper2 and Susan A Slaugenhaupt1*
Abstract
Mucolipidosis IV (MLIV) is caused by mutations in the gene MCOLN1. Patients with MLIV have severe neurologic
deficits and very little is known about the brain pathology in this lysosomal disease. Using an accurate mouse
model of mucolipidosis IV, we observed early behavioral deficits which were accompanied by activation of
microglia and astrocytes. The glial activation that persisted during the course of disease was not accompanied by
neuronal loss even at the late stage. In vivo [Ca2+]-imaging revealed no changes in resting [Ca2+] levels in Mcoln1−/−
cortical neurons, implying their physiological health. Despite the absence of neuron loss, we observed alterations in
synaptic plasticity, as indicated by elevated paired-pulse facilitation and enhanced long-term potentiation. Myelination
deficits and severely dysmorphic corpus callosum were present early and resembled white matter pathology in
mucolipidosis IV patients. These results indicate the early involvement of glia, and challenge the traditional view of
mucolipidosis IV as an overtly neurodegenerative condition.
Keywords: Mucolipidosis IV, Lysosomal storage disease, Neuropathology, In vivo Ca2+ imaging, Glia
Introduction
Mucolipidosis IV (MLIV) is a lysosomal storage disorder
(LSD) with autosomal recessive inheritance caused by
loss of function of mucolipin-1 (also known as TRPML1).
Over 20 different MCOLN1 gene mutations have been
identified in MLIV patients, although the two founder
mutations, both leading to complete loss of mRNA and
functional protein, account for ~95% of all MLIV alleles
and show a carrier frequency of 1:100 in the Ashkenazi
Jewish population [1]. The most profound clinical mani-
festations of MLIV are severe psychomotor retardation
during the first year of life and slowly progressing vision
loss due to corneal clouding and retinal degeneration
resulting in blindness by the second decade of life [2-4].
Neuromotor abnormalities include delayed attainment
of motor milestones, spasticity, hypotonia, inability to
walk independently, ptosis, myopathic facies, drooling,
difficulties in chewing and swallowing, and severely im-
paired fine-motor function. Most patients reach a level
of motor, speech and cognitive development of about
15 months, and remain neurologically stable during sec-
ond and third decade of life [5,6]. The most striking
MRI findings in MLIV include a dysplastic corpus callo-
sum, widespread white matter abnormalities, including
abnormal diffusion weighed imaging values: increased
mean diffusivity and decreased fractional anisotropy, de-
creased T2 signal intensities in the thalamus due to in-
creased ferritin deposition, and cerebellar atrophy in older
patients [6-8]. At the cellular level MLIV results in the for-
mation of abundant electron-dense inclusions composed
of lipid-like (lamellated) and polysaccharide-like (granular)
material, referred to as “compound bodies” [9,10].
TRPML1 functions as a non-specific cation channel
[11-13]. Previous studies by our group and others showed
TRPML1 localization to late endosomes and lysosomes
(LEL) [14-17], and its involvement in lipid trafficking
[18,19]; Ca2+-dependent LEL fission-fusion events [19]; ref-
ormation of lysosomes from endosome-lysosome hybrids
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[17,20] and autolysosomes [21,22]; and lysosomal exocyt-
osis [23,24]. However, the endogenous localization and
function of TRPML1 in both neurons and glial cells in the
brain have yet to be defined.
A mouse model of MLIV created in our laboratory was
shown to accurately recapitulate the key features of the
human disease [25]. At birth, the Mcoln1 knock-out mice
display no overt phenotypes; limb weakening is observed
at the age of 3 months and progresses to total hind limb
paralysis and death by approximately 8 months. Ultra-
structural analysis revealed presence of the storage inclu-
sions in neurons and all types of glial cells. Inclusions
resemble the “compound bodies” reported in MLIV pa-
tients and are detectable in the embryonic mouse brain.
Histological analysis of end-stage brains revealed accumu-
lation of gangliosides, cholesterol and P62/SQSTM1, as
well as glial activation and reduced myelination [26]. The
mechanisms that link loss of TRPML1 with brain path-
ology and the devastating neurological symptoms of
MLIV remain unclear, and there is currently no treat-
ment for the disease. Therefore, study of the MLIV
mouse model is an essential step toward understanding
disease pathogenesis and for testing potential therapies.
Here we investigate the onset and progression of neuro-
logical phenotypes in Mcoln1−/− mice using behavioral
testing, systematic volumetric and neuropathologic ana-
lysis of post-mortem brain tissue, in vivo multiphoton
imaging of resting [Ca2+] concentration and electrophysi-
ology. Our data indicate an early and profound involve-
ment of glial cells in pathogenesis of MLIV, a disease
traditionally viewed as being “neuronal”, and provide new
clues to the development of therapies for this devastating
disorder.
Materials and methods
Animals
Mcoln1 knock-out mice were maintained and geno-
typed as previously described [25]. The Mcoln1+/−
breeders for this study were obtained by backcrossing
onto a C57Bl6N background for more than 10 genera-
tions. Mcoln1+/+ littermates were used as controls. Experi-
ments were performed according to the institutional and
US National Institute of Health guidelines and approved
by the Massachusetts General Hospital Institutional Animal
Care and Use Committee.
Open field testing
Open field testing was performed on naive male mice at
one (n = 13, wild type; n = 9, Mcoln1−/−) and two (n = 17,
wild type; n = 18, Mcoln1−/−) months of age under regu-
lar light conditions. Each mouse was placed in the center
of a 27 × 27 cm2 Plexiglas arena, and the horizontal and
vertical activity were recorded by the Activity Monitor
program (Med Associates). Data were analyzed during
the first 10 mins in the arena. Zone analysis was per-
formed to measure movements/time spent in the central
(8 × 8 cm2) versus peripheral (residual) zone of the arena.
Data were analyzed by two-way ANOVA (genotype × age)
followed by Bonferroni post-test.
Stereological analysis and immunohistochemistry
To obtain brain tissue for histological examination two
(n = 6 per genotype), three (n = 3, WT; n = 4, Mcoln1−/−)
and seven month-old Mcoln1−/− and control mice (n = 4
per genotype) were transcardially perfused under isoflur-
ane anesthesia with ice-cold phosphate buffered saline
(PBS) followed by 4% paraformaldehyde in PBS. Brains
were postfixed in 4% paraformaldehyde in PBS for
24 hours, washed with PBS, cryoprotected in 30% su-
crose in PBS overnight, frozen in isopentane and stored
at −80°C. Brains were bisected along the midline and
one hemisphere was examined histologically. 40 μm
coronal sections were cut using a Microm freezing
microtome and collected into 96 well plates containing
TBSAF (TBS, 30% ethylene glycol, 15% sucrose, 0.05%
sodium azide). These sections were stored at 4°C prior
to any staining procedures. For Nissl staining a one-in-six
series of sections were mounted onto chrome gelatine
coated slides, incubated in 0.05% cresyl violet stain and
0.05% acetic acid at 60°C for 30 mins before being dehy-
drated in ascending concentration of industrial methylated
spirits (IMS) followed by xylene. The sections were then
coverslipped using DPX mountant.
Quantitative histological measurements
Nissl stained sections were used to obtain cortical thick-
ness measurements using StereoInvestigator software. All
analyses were carried out using ×2.5 objective on a Zeiss,
Axioskop2 MOT microscope (Carl Zeiss Ltd, Welwyn
Garden City, UK). Briefly, within each region three con-
secutive sections were chosen and 10 perpendicular lines
were drawn from the pial surface to the white matter.
Unbiased Cavalieri estimates of regional volume were
obtained using StereoInvestigator software. Briefly, for
each of the regions a sampling grid size of 150 μm was
superimposed on every one-in-twelfth Nissl stained sec-
tion (cortex and hippocampus) or every one-in-six Nissl
stained section (thalamus and striatum) and the number
of points that fell within this region was recorded to pro-
vide an unbiased Cavalieri estimate of regional volume
(μm3) for each brain. All measurements were carried out
at ×2.5 objective on the Olympus BX50 microscope
(Olympus Microscopes, South-on-Sea, UK).
Unbiased optical fractionator estimates for the number
of Nissl stained neurons within the VPL-VPM, laminae
IV and V of the S1BF, DLG and red nucleus were ob-
tained using the StereoInvestigator program. A grid size
of 175 μm × 175 μm was used for the thalamus, 225 μm
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× 225 μm was used for laminae IV and V of the S1BF,
and 125 μm × 125 μm was used for the DLG and red
nucleus. A counting frame of 68 cm × 38 cm was used
for all regions and all measurements were carried out at
×100 objective on a Zeiss, Axioskop2 MOT microscope
(Carl Zeiss Ltd, Welwyn Garden City, UK). The mean
coefficient of error (CE) for optical fractionator esti-
mates of neuron number were all between 0.05 and 0.1.
All analyses were performed blind to genotype, which
was only revealed once these analyses were complete. At
this point the mean value for each parameter was calcu-
lated for both Mcoln1-deficient and +/+mice. Differences
between genotypes were compared statistically using
Student’s t-tests with a P-value of ≤ 0.05 considered as
statistically significant.
Immunostaining
Immunostaining was performed as described [27]. The
primary polyclonal rat anti-CD68 (Serotec, 1:2000) and
polyclonal rabbit anti-GFAP (DAKO, 1:4000) antibodies
were used. For myelin FluoroMyelin™ Green fluorescent
stain (Molecular Probes) was used according to the manu-
facturer protocol.
Thresholding image analysis
Three consecutive GFAP- and CD68- immunostained
sections were chosen for each of the regions being ob-
served and 30 non-overlapping images were captured
at 40× objective by a live video camera (JVC, 3CCD,
KY-F55B) mounted on Zeiss Axioplan microscope (West
Germany). The lamp intensity, video camera setup, and
calibration were kept constant when capturing all the im-
ages. These images were then analysed on ImageProPlus
software with an appropriate threshold selected to distin-
guish the foreground immunostaining above the back-
ground for each of the age groups being observed. The
data obtained from the thresholding analysis was plotted
graphically as a mean percentage area of immunoreactivity
per image.
In vivo imaging of Ca2+ concentrations in cortical neurons
To deliver the genetically encoded calcium indicator,
craniotomies were performed on Mcoln1−/− (n = 5) and
control mice (n = 3) of 2 months and 1 week of age. A
5-mm diameter skull flap centered over the right pri-
mary somatosensory cortex was removed and 2 μl of
AAV2/8 viral vector (5.6 × 1012 viral genomes/ml) en-
coding YC3.60 under hybrid cytomegalovirus (CMV)
immediate-early enhancer/chicken β-actin promoter/
exon1/intron [28] were injected into the open brain
close to the center of the craniotomy at a depth of about
0.5 mm and at a speed of 0.2 μl/min. The brain surface
(still covered by intact dura matter) was kept moist with
Ringer’s solution at all times. Following the virus injection,
the craniotomy was sealed with a glass coverslip and
cemented with dental acrylic. Appropriate anesthetic
and analgesic regimes were followed before, during and
after the surgery. 3 weeks after the surgery, when the
mice reached 3 months of age, they were anesthetized
(isoflurane in balanced oxygen: 4% for 5 min induction,
then maintained at 1.2%), head fixed and imaged on a
multiphoton microscope. Our imaging setup was de-
scribed earlier [29]. The excitation laser was tuned to
860 nm and the output power before the objective was
set to 30 mW. Emitted light was collected in three chan-
nels: 460 – 500 nm (cyan channel (C), CFP fluorescence),
530 – 560 nm (yellow channel (Y), YFP fluorescence) and
575 – 630 nm (red channel (R), autofluorescence from
storage material). With these settings, autofluorescent
storage material yielded equal signals in cyan, yellow and
red channels. Z-stacks were acquired with the resolution
of 0.5 μm/voxel in X-Y dimension and the Z-step of 3 μm
for imaging of neuronal cell bodies in the cortical layer II/
III (512 × 512 × 270 μm stack) and with the resolution of
0.25 × 0.25 × 2 μm/voxel for imaging of dendrites in the
cortical layer I (512 × 512 × 60 μm stack). Imaging set-
tings were kept constant across mice.
Image processing was performed using the Fiji package
of NIH ImageJ software (fiji.sc; rsbweb.nih.gov/ij) and
MATLAB (MathWorks). Ratio of YFP to CFP signals
representative of intracellular calcium concentration was
calculated after subtracting the signal from background-
subtracted red channel: R ¼ Y−RC−R . Regions of interest
(ROIs) outlining cell bodies and dendrites were selected
on the raw images and applied to the ratio images and to
the red channel to estimate the amount of autofluorescent
storage. The values for individual cells and dendrites were
calculated as mean ratio in ROIs. All statistical tests were
performed on R values. To convert R values to [Ca2+]
for data presentation and interpretation, the following
formula was used: Ca2þ½  ¼ K ′d R−RminRmax−R
 1
n=
. Values for K ′d
(277 nM) and the Hill coefficient n (1.1) were de-
scribed previously [28]. Rmin (0.67) and Rmax (2.55) were
measured experimentally. To create pseudocolored im-
ages, ratio images coded with “Rainbow RGB” lookup
table were converted to the RGB space weighted by
intensity.
The normality of datasets of YC3.60 ratio values was
tested using Kolmogorov-Smirnov method. Since the
distributions were found to be non-normal, they were
compared between genotypes using the Wilcoxon rank-
sum test with correction for clustering of values within in-
dividual mice [30]. The correlation of YC3.60 ratio values
with the amount of cytosolic storage material was per-
formed using a mixed effects model, with random slope
effects for mouse, and using mouse-specific standardized
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transformations of YC3.60 ratio and autofluorescence
values.
Electrophysiology
Transverse hippocampal slices were prepared from
7 month-old Mcoln1−/− and control male mice (n = 6
per genotype) and field recordings were performed as
described [31]. Data were normalized to the baseline
response and are presented as group means ± SE. One-
way ANOVA and Student’s t-test were used to determine
statistically significant differences. For all experiments the
experimenter was blind to genotype.
Electron microscopy
Seven month-old Mcoln1−/− and control mice (n = 4 per
genotype) were anesthetized with isoflurane and transcar-
dially perfused with PBS followed by 2% paraformalde-
hyde/2% glutaraldehyde in PBS, brains were removed and
50 μm coronal serial vibratome sections were processed
for EM as previously described [32]. 35 micrographs per
sample from stratum radiatum per mouse were obtained
on a JEOL JEM-1011 transmission electron microscope at
final magnification of ×25,000. Only asymmetric macular
(non-perforated) synapses that were fully present on the
micrograph were included in the analysis. Digital image
analysis was performed using ImageJ (NIH). The post-
synaptic density length was measured. Analysis of mito-
chondrion volume was performed as described [33]. For
myelin sheath thickness measurements two perpendicular
lines were drawn through the center of each myelinated
axon and four measurements of the thickness were taken
at each intersection with the myelin sheath with the mean
value of four measurements calculated. The normality of
all data sets was tested using the Kolmogorov-Smirnov
method. Non-parametric data are presented as median
values with interquartile ranges. An extended Wilcoxon
rank-sum test that accommodates clustered data was used
for comparisons between control and Mcoln1−/− groups
for non-normally distributed data. Statistical significance
threshold was set at p < 0.05.
Results
Early motor and cognitive deficits in Mcoln1−/− mice
To determine if Mcoln1−/− mice display early locomotor
and behavioral deficits, spontaneous activity of one- and
two-month-old naïve Mcoln1−/− mice and wild-type lit-
termates was tested in the open field arena. We found a
significant decline in both jumping and vertical activity
and an increase in the resting time in Mcoln1−/− mice at
two months of age (Figure 1A-E), which indicates the
early onset of motor deficits. Analysis of activity within
the central zone revealed that the number of central
zone entries, percentage of central track length and per-
centage of time spent in the center were significantly
lower in Mcoln1−/− mice compared to wild-type controls
at 2 months of age (Figure 1F-H) indicating an early de-
cline in the exploratory activity associated with loss of
Mcoln1.
Absence of brain atrophy in Mcoln1−/− brain
Neuropathology in models of lysosomal storage disor-
ders is typically characterized by atrophy and neuronal
loss within specific brain regions. To assess the progres-
sion of anatomical changes in the Mcoln1−/− brain, we
performed unbiased stereological measurements of the
volume of four brain regions (cortex, hippocampus, thal-
amus and striatum) in two, three and seven month-old
mice. We observed no atrophy of any of these brain re-
gions at any of these three time points (Additional file 1:
Figure S1A). Next we assessed whether more subtle effects
were evident within the cortex of these mice by obtaining
cortical thickness measurements from the somatosensory
barrelfield cortex (S1BF), primary motor cortex (M1), lat-
eral entorhinal cortex (LEnt) and primary visual cortex
(V1) at two, three and seven months. No significant
changes in cortical thickness were detected between
Mcoln1−/− and control mice at any age (Additional file 1:
Figure S1B), suggesting that none of the examined regions
of cortex undergoes overt neurodegeneration during the
course of this disease.
Profound early activation of microglia and astrocytes in
Mcoln1−/− mice
Since pronounced activation of microglia and astrocytes
has been reported in the single available autopsy report
from an MLIV patient [9], and in end-stage Mcoln1−/−
mice [26], we evaluated the onset and progression of
these phenotypes in brain tissue from two, three and
seven month-old Mcoln1−/− mice. Immunostaining for
the astrocyte marker GFAP revealed marked reactive
astrocytosis in Mcoln1−/− brains as early as two months
of age. At this time we observed an intense GFAP im-
munoreactivity in the somatosensory barrelfield cortex,
primary motor cortex and hypothalamus, with the most
prominent staining intensity in the VPL/VPM region of
thalamus (Figure 2A, B). Astrocytosis in Mcoln1−/− mice
progressed with age, and by the age of seven months in-
tensely stained GFAP-positive cells were present through-
out the entire area of thalamus and hypothalamus. These
GFAP-positive astrocytes within the Mcoln1−/− brain ap-
peared hypertrophied with enlarged soma and thickened
processes. However, astrocytosis appeared to progress at
different rates between brain regions. For example, stain-
ing for GFAP was more pronounced in VPL/VPM at earl-
ier stages of disease, and only subsequently became more
evident in S1BF, the target cortical region for this somato-
sensory relay nucleus of the thalamus (Figure 2C). Thresh-
olding image analysis in the VPL/VPM area of thalamus
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revealed a significant effect of age and genotype on GFAP
staining intensity (F genotype × age = 5.67; p < 0.0107) with
increased staining in Mcoln1−/− mice at two and three
months of age (post-hoc t-test with Bonferroni correction:
p 2 months < 0.05; p 3 months < 0.001; p 7 months > 0.05). GFAP
staining intensity in S1BF cortex was also significantly
affected by genotype and age (F genotype × age =5.54; p =
0.0117), however post hoc test revealed significant in-
crease in GFAP in Mcoln1−/− mice only at the age of seven
months (p < 0.01).
To examine the microglial response, brain tissue from
two, three and seven month-old Mcoln1−/− mice and
wild-type littermates was immunostained for the microglia/
macrophage marker CD68. Compared to the wild-type
controls, the Mcoln1−/− mice displayed pronounced acti-
vation of microglia early in disease progression, which was
evident at two months of age, especially within the VPL/
VPM (Figure 2D), throughout the cortex (Figure 2E),
hippocampus, DLG and red nucleus (not shown). However,
microglial response became less pronounced and wide-
spread in Mcoln1−/− mice at seven months of age. Micro-
glia in control mice were faintly stained and exhibited a
ramified morphology with a small cell body, whereas in
the Mcoln1−/− mice they were much more intensely
stained and displayed more rounded and enlarged cell
bodies, with short thickened processes characteristic of
activated microglia or brain macrophages (Figure 2D, E).
Thresholding image analysis in the VPL/VPM region of
thalamus followed by two-way ANOVA test showed a sig-
nificant effect of genotype (F genotype = 11.54; p = 0.0027),
and no effect of age (F age = 0.098; p = 0.91) on CD68
staining intensity (Figure 2F). Analysis of CD68 staining
in the S1BF region of the cortex revealed significant ef-
fect of genotype and age (F genotype × age = 4.1; p = 0.03),
with a significant increase in CD68 staining intensity at
two (p < 0.001) and three (p < 0.001), but not at seven
months (Figure 2E, F), when activated microglia ap-
peared to be more localized to lamina IV. Similar
changes in microglia morphology and increased staining
intensity were observed with the microglial marker Iba1
(Additional file 2: Figure S2).
Ultrastructural analysis of the brain tissue (CA1 stratum
radiatum of hippocampus) at seven months revealed accu-
mulation of electron-dense storage bodies in Mcoln1−/−
astrocytes similar to those described previously in the cor-
tex [25] (Additional file 3: Figure S3A). We also observed
the formation of large aggregates of electron-dense organ-
elles (or clumps). Most often they were engulfed by the
Figure 1 Motor and exploratory activity in the open field test is decreased in the two month-old Mcoln1−/− mice. Data presented as
mean values ± SEM for 8 wild-type (WT) and 13 Mcoln1−/− (KO) one month-old and 17 wild-type and 18 Mcoln1−/− two month-old mice. Each
mouse, at either one or two months of age, was tested once in the open field and spontaneous activity during 10 min of exploration in the
open-field arena was recorded. Two-way ANOVA analysis revealed: significant interaction between age and genotype in jump counts
(F genotype × age = 6.96, p = 0.0271) (A) and jump time (F genotype × age = 5.36, p = 0.0409) (B); significant effects of age and genotype on vertical
activity, expressed as rearing (F genotype = 6.16, p = 0.0155; F age = 38.09, p < 0.0001) (C), and vertical time (F genotype = 3.87, p > 0.05; F age = 38.7,
p < 0.0001) (D), resting time (F genotype = 6.91, p = 0.0128; F age = 35.75, p < 0.0001) (E) and exploratory activity, expressed by percentage of central
track length (F genotype = 11.15, p = 0.0087; F age = 8.69, p = 0.0197) (F), percentage of time spent in the center (F genotype = 9.99, p = 0.0111;
F age = 10.12, p = 0.0106) (G) and the number of central zone entries (F genotype × age = 5.36, p = 0.0409) (H). Asterisks indicate significant difference
between genotypes at given time-points as determined by post-hoc t-test with Bonferroni correction, p* - <0.05, ** - <0.01, *** - <0.001.
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plasma membrane which lacks synaptic contacts and,
based on cell morphology [34], most likely belongs to
microglia/macrophages (Additional file 3: Figure S3B).
Normal resting calcium concentrations in the
somatosensory cortex of Mcoln1−/− mice
To assess if loss of TRPML1 and the early activation of
glia resulted in sub-lethal neurotoxicity and impaired
calcium homeostasis, we performed in vivo measure-
ments of intracellular calcium concentrations in cortical
neurons of Mcoln1−/− and wild-type mice expressing the
genetically-encoded ratiometric calcium sensor YC3.61
[28,35]. An adeno-associated viral vector (AAV 2/1) was
used to deliver YC3.61 to layer II/III neurons of the
somatosensory cortex, a region where pronounced astro-
cytosis and microglial activation is present (Figure 2).
Resting [Ca2+] was determined in the individual cell
bodies and dendrites by in vivo multiphoton imaging of
the injected area through implanted cranial window [28]
in anesthetized mice. Analysis of resting calcium concen-
tration in three month-old mice revealed no differences
in either neuronal somata in layers II/III (Figure 3A, C)
(3 WT mice, 888 cells; 5 KO mice 1875 cells analyzed)
or neuropil in layer I (Figure 3B, D) (3 WT mice, 312
neurites; 5 KO mice 536 neurites analyzed). Resting
[Ca2+] levels in the dendrites of both KO mice and control
littermates were in good concordance with the previously
reported values for wild-type mice [28]. Additionally, we
observed large autofluorescent storage aggregates in the
cytosol of Mcoln1−/− neurons (Figure 3E) which, however,
had very little effect on the levels of intraneuronal resting
[Ca2+] (R = −0.074, p = 0.04), and even the cells with the
highest amount of storage material had physiologically
normal [Ca2+] levels (Figure 3E, F). These data show that
the loss of TRPML1 does not result in neuroexcitotoxicity
and provides evidence of physiological health of Mcoln1−/−
neurons at three months of age despite profound activation
of microglia and astrocytes in the somatosensory cortex
at this age.
Activation of microglia and astrocytes is not accompanied
by neuronal loss in Mcoln1−/− mice
Activation of microglia has been linked to neuron loss in
many neurodegenerative diseases [36]. To assess if chronic
activation of microglia was associated with neuronal loss
in Mcoln1−/− mice later in disease progression, unbiased
optical fractionator neuron counts were obtained in the
brain areas with the most prominent microgliosis, i.e.
the VPL/VPM region of thalamus, laminae IV and V of
the somatosensory barrelfield cortex, the CA1 and CA3
subfields of the hippocampus, the DLG and red nucleus,
in seven month-old mice (Additional file 4: Figure S4).
We observed no significant differences in neuron num-
ber between wild type and Mcoln1−/− mice in any of the
examined regions, suggesting that activation of micro-
glia was not caused by or resulted in neuronal death in
the Mcoln1−/− brain.
Abnormal synaptic plasticity in Mcoln1−/− mice
Since our data show no overt neuronal loss in the
Mcoln1−/− brain, we next examined the consequence of
loss of TRPML1 on neuronal function, which might ex-
plain the severe motor and cognitive decline in MLIV. To
assess synaptic function, we performed field recordings in
the Schaeffer collateral pathway of acute hippocampal
slices from seven month-old control and Mcoln1−/− mice
(n = 6). First, we examined basal synaptic transmission by
measuring the synaptic input–output relationship, plotting
the slope of the field excitatory postsynaptic potential
(fEPSP) as a function of the presynaptic fiber volley ampli-
tude at varying stimulus intensities. Our results revealed a
non-significant trend toward decreased synaptic input–
output coupling in the Mcoln1−/− relative to control mice
(p = 0.08) (Figure 4A). Second, we analyzed paired-pulse
facilitation (PPF), a short-term form of presynaptic
plasticity in which paired stimulation with a short
inter-stimulus interval elicits a transient enhancement in
neurotransmitter release. We observed significantly ele-
vated PPF in the Mcoln1−/− hippocampus at the shortest
(See figure on previous page.)
Figure 2 Reactive astrocytosis and activation of microglia in Mcoln1−/− mice. Representative images of GFAP immunostaning in wild-type
(WT) and Mcoln1−/− (KO) littermates at two, three and seven months of age showing increased immunoreactivity in KO in thalamus (A) or
somatosensory barrelfield cortex (B). Scale bar is equal to 500 μm in low magnification images, 50 μm in higher magnification images of thalamic
area and 150 μm in the images of cortex. Black selection area shows an example of VPL/VPM area of thalamus used for thresholding analysis,
represented in (C). (C). Thresholding analysis of GFAP staining intensity performed for VPL-VPM region of thalamus and S1BF cortex in wild-type
(WT) and Mcoln1−/− (KO) littermates at two (n = 6 per genotype), three (n (WT) = 3; n (KO) = 4) and seven months of age (n = 4 per genotype).
Data presented as mean values ± SEM. Two-way ANOVA revealed significant effect of age and genotype. Post-hoc t-test with Bonferroni correction:
* - p < 0.05; *** - p < 0.001. (D), (E). Representative images of CD68 immunostaning in wild-type (WT) and Mcoln1−/− (KO) littermates at two, three and
seven months of age showing increased immunoreactivity in KO in thalamus (D) or somatosensory barrelfield cortex (E). Scale bars as in (B). Black
selection area shows an example of VPL-VPM area of thalamus used for thresholding analysis, represented in (F). (F). Thresholding analysis of CD68
staining intensity in VPL/VPM region of thalamus and S1BF cortex in wild-type (WT) and Mcoln1−/− (KO) littermates at two (n = 6 per genotype), three
(n (WT) = 3; n (KO) = 4) and seven months of age (n = 4 per genotype group). Data presented as mean values ± SEM and analyzed by two-way ANOVA
and post-hoc t-test with Bonferroni correction: *** - p < 0.001.
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inter-stimulus intervals (ISI) (Figure 4B), implying that
TRPML1 deficiency may affect neurotransmitter release.
We also examined the impact of TRPML1 loss on synaptic
plasticity by analyzing long-term potentiation (LTP), a
long-lasting enhancement of synaptic strength induced by
patterned high-frequency stimulation, which is thought to
model synaptic modifications underlying learning and
memory. Experiments in which LTP was induced by mul-
tiple trains of tetanic stimulation revealed that loss of
TRPML1 led to significantly enhanced LTP (Figure 4C).
Figure 3 Intracellular resting [Ca2+] is normal in the cortical neurons of Mcoln1−/− mice. Frequency distributions of resting intracellular
[Ca2+] levels in the neuronal cell bodies in the primary somatosensory cortical layer II/III (A) and in the apical dendrites of these neurons in the
layer I (B). N.s. – no significant difference in distributions between WT and KO mice; p = 0.49 (cell bodies), p = 0.86 (dendrites); n = 536 dendrites
and 1825 neurons from 5 mice (KO), n = 312 dendrites and 888 neurons from 3 mice (WT), assessed using clustered rank-sum test [30]. Maximum
intensity Z-projections of representative 75-μm thick multiphoton image stacks demonstrating YC3.60 expression in neuronal cell bodies in layer
II/III (C) and in apical dendrites in layer I (D). The projections were pseudocolored based on measured [Ca2+] levels. Scale bar = 50 μm (C), 20 μm
(D). (E). Representative multiphoton sections from layer II/III of somatosensory cortex of Mcoln1−/− and control mice demonstrating intracellular
autofluorescent storage material in the YC3.60-expressing neurons. YC3.60 expression is displayed as the sum of signals in the cyan and yellow
channels. Scale bar = 50 μm. (F). Plot of intracellular [Ca2+] in the neuronal cell bodies in KO mice versus the amount of autofluorescent cytosolic
storage material in the same cells. Solid red line shows linear regression, dotted red line – 95% confidence interval. Correlation coefficient = −0.074,
p = 0.04. AU = arbitrary units of fluorescence. n = 1825 neurons in 5 mice.
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Alterations in synapse morphology in Mcoln1−/− mice
To determine if there were morphological changes associ-
ated with altered synaptic plasticity in Mcoln1−/− mice, we
performed electron microscopic analysis of synaptic ter-
minals in the CA1 stratum radiatum of 7 month-old mice.
We observed elongated post-synaptic densities (PSD) in
excitatory (asymmetric) synapses (p = 0.024) in Mcoln1−/−
mice compared to control littermates (Figure 4D, E).
Quantification of the asymmetric synapse density in CA1
stratum radiatum showed a trend towards a decrease in
Mcoln1−/− mice, but this did not reach statistical significance
due to high variability (Figure 4F). Since axonal pathology
is often accompanied by mitochondrial stress, we mea-
sured volume of mitochondria in neuropil of CA1 stratum
radiatum inMcoln1−/− and control mice, but found no dif-
ference (Figure 4G).
Loss of Mcoln1 results in the early defects of myelination
The most remarkable ultrastructural feature observed by
electron microscopy in the stratum radiatum of Mcoln1−/−
mice was reduced myelination (Figure 5A). Morphometric
analysis revealed significant thinning of the myelin sheaths
Figure 4 Synaptic plasticity and altered synapse morphology in Mcoln1−/− mice. (A). Basal synaptic transmission: the synaptic input–output
curve shows fEPSP slopes as a function of fiber-volley amplitudes for wild-type (n = 24 slices, 6 mice) and Mcoln1−/− (n = 26 slices, 6 mice). The
lines represent linear regression of the data; p = 0.08. (B). The paired-pulse facilitation (PPF) is enhanced in Mcoln1−/− mice. The facilitation ratio is
shown as a function of interpulse interval (ISI) for wild-type (n = 29 slices, 6 mice) and Mcoln1−/− (n = 31 slices, 6 mice) slices. *, p < 0.05. (C).
Increased LTP in Mcoln1−/− mice. LTP was induced in control (n = 18 slices, 6 mice) and Mcoln1−/− slices (n = 16 slices, 6 mice) with 4 tetanic trains
(100 Hz, 1 s) separated by 5 min each. *, p < 0.05. fEPSP recordings were filtered at 1 kHz, digitized at 20 kHz, and analyzed using pClamp10 (Axon
Instruments). (D). Electron micrographs of CA1 stratum radiatum: white arrowheads indicate examples of PSDs in macular excitatory (glutamatergic)
synapses included in the analysisin (E); black arrows show post-synaptic densities of active zones in the perforated excitatory synapses omitted from
the analysis. Mth, mitochondria; gl, process of a glial cell; sp – dendritic spine. (E). PSD length quantification in 4 control and 4 Mcoln1−/− mice, total
number of 433 control and 402 Mcoln1−/− synapses. Data presented as median values with interquartile range, *, p (clustered rank-sum test) <0.05.
(F). Synapse density quantification. Each data point represents the average number of synapses per μm2 per mouse; line bars represent average value
per genotype group and SEM; p (Student’s t-test) >0.05. (G). Volume of mitochondria: total number of 1262 control and 1196 Mcoln1−/− mitochondria
measured (n = 4 mice per genotype); n.s., p (clustered rank-sum test) > 0.05.
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as shown by significantly lower g-ratio (axon diameter/
fiber diameter, where fiber diameter is a sum of axon
diameter and myelin sheath thickness) in Mcoln1−/−
mice (Figure 5B). No significant difference was observed
in the diameter of myelinated axons between the two
genotypes (Figure 5C). Impaired CNS myelination and a
dysgenic corpus callosum are hallmarks of neuropathol-
ogy in MLIV patients, and a decreased Luxol fast blue
staining has been previously reported in the corpus cal-
losum, deep layers of neocortex and cerebellar white
matter tracts of the end-stage Mcoln1−/− mice [26]. To
follow the time-course of myelination deficits, we set
out to measure myelination in two and seven month-old
Mcoln1−/− mice using FluoroMyelin Green stain. Analysis
of coronal sections (Figure 5D) revealed profound thin-
ning of the corpus callosum and reduced myelination of
internal capsule in Mcoln1−/− mice at both time points.
Strikingly, we observed no anterior commissure (AC) in
the Mcoln1−/− mice at two months. However, a dys-
morphic and smaller AC appeared in the sections from
Figure 5 Myelination is impaired in Mcoln1−/− mice. (A). Representative electron micrographs of CA1 stratum radiatum in 7 month-old control
(WT) and Mcoln1−/− (KO) mice showing reduced thickness of myelin sheaths. (B). G-ratio (axon diameter/fiber diameter) plotted against axon
diameter shows reduced degree of myelination in Mcoln1−/− (124 axons; 4 mice) compared to wild-type (231 axon; 4 mice) 7 month-old
littermates, p (clustered rank-sum test) = 0.018. (C). Comparison of axon diameters revealed no significant difference between control (WT) and
Mcoln1−/− (KO) littermates. Data presented as median values with interquartile range, n.s., p (clustered rank-sum test) = 0.28. (D). Representative
images of FluoroMyelin Green- stained coronal sections show reduced myelination of corpus callosum, internal capsule and anterior commissure
(indicated by white arrowheads) in Mcoln1−/− brain and thinning of the corpus callosum (n = 3 per genotype at 2 months, n = 5 per genotype at
7 months; p (t-test) <0.01). (E). Representative images of FluoroMyelin Green- stained sagittal sections (counterstained with DAPI) demonstrate
malformation of the corpus callosum in the Mcoln1−/− at 2 months. S-splenium, G-genu, R-rostrum. Scale bars = 0.5 mm.
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seven month-old mice (Figure 5D). Analysis of the
FlyoroMyelin Green staining in the sagittal sections re-
vealed malformation of the corpus callosum (CC) in the
Mcoln1−/− mice. Specifically, similar to MLIV patients,
Mcoln1−/− mice displayed a generally hypomorphic cor-
pus callosum, with dysgenic rostrum and dysgenic or
absent splenium compared to WT littermate controls
(Figure 5E).
Discussion
The most striking clinical manifestation of MLIV is psy-
chomotor retardation resulting in the developmental ar-
rest of motor, speech and cognitive function at the level of
about 15 months. Thus, understanding the early patho-
logic events leading to neurologic and visual impairment
is of prime importance for designing an effective therapy
for MLIV. To study the first signs of neuropathology and
to follow their maturation with disease progression, we
performed open field testing on young animals and corre-
lated our findings with systematic volumetric and histo-
pathologic analysis and in vivo resting calcium imaging of
the Mcoln1−/− mouse brain. Our results reveal that early
motor and cognitive deficits in Mcoln1−/− mice are associ-
ated with white matter abnormalities, including hypogen-
esis of the corpus callosum, and pronounced activation of
microglia and astrocytes, which is unexpectedly not ac-
companied by neurotoxicity or neuronal loss. However,
we observe disrupted synaptic function, and increased
length of asymmetric postsynaptic densities in excitatory
synapses in the hippocampus of a MLIV mouse model at
the late stage of disease.
Given the early onset of psycho-motor disabilities in
patients with MLIV [5,37], we tested spontaneous loco-
motor and exploratory activity in juvenile one month-
old or two month-old young adult mice. Our results re-
vealed that the overall performance in the open field test
changes with age, with a significant increase in the wild-
type littermates’ activity at two months of age compared
to one month. However, while we observed no significant
differences between the performance of one month-old
wild-type and Mcoln1−/− mice, these mutant mice fail to
undergo the normal developmental progression and showed
significantly decreased jumping, rearing and exploratory ac-
tivity at two months compared to their control littermates,
indicating an onset of the locomotor and potentially cog-
nitive decline due to the loss of TRPML1 at this age.
A striking early phenotype that we observed inMcoln1−/−
mice was activation of microglia and astrocytes. Activation
of astrocytes has also been reported in the only brain
autopsy case described in MLIV [9], where, based on
general observations of reactive astrocytes accompanying
neuronal death in other neurodegenerative conditions, it
was thought to mark neuronal loss. Reactive astrocytes
and microgliosis have been observed in mouse models
of other LSDs, including the NCLs [27,38–43], mucopo-
lysaccharidosises [44]; Neimann-Pick disease [45] and
mucolipidosis II [46]. In many of these models, neuroin-
flammation develops early and precedes neuronal loss
in the gliosis-affected brain regions. However, our data
show that in Mcoln1−/− mice gliosis was not accompan-
ied by neuronal loss even at the late stage of the disease.
To determine if the loss of TRPML1 or the activation
of microglia or astrocytes observed in the Mcoln1−/− brain
affects the physiological status of neurons, we measured
resting concentrations of Ca2+ in neuronal somata and
neuropil in the somatosensory cortex using in vivo multi-
photon microscopy with genetically encoded calcium indi-
cator YC3.60. The ability of neurons to maintain calcium
homeostasis is a functional read-out of neuronal “health”.
Overload of calcium leading to activation of calcineurin-
dependent neurodegenerative processes has been dem-
onstrated in the neurites of several mouse models of
Alzheimer’s disease [28]. Moreover, in MLIV, intracel-
lular calcium dyshomeostasis due to loss of TRPML1, a
lysosomal cation channel permeable to Ca2+, has been
suggested in the literature as a primary mechanism of the
disease [47,48]. Surprisingly, we observed no changes in
resting Ca2+ concentration and virtually no effect of cyto-
solic storage material on intracellular [Ca2+] in Mcoln1−/−
neurons of somatosensory cortex at the age of three
months, implying spared physiologic status of neurons
and absence of excitotoxicity in spite of TRPML1 loss and
widespread reactive gliosis in the brain at this age.
Interestingly, in the hippocampus, activation of micro-
glia, which did not cause or result in the loss of CA1 or
CA3 neurons, was accompanied by electrophysiological
alterations (enhanced PPT and LTP) in the Schaeffer col-
laterals of the Mcoln1−/− mice. Of particular interest is
the fact that re-expression of trpml in glial cells in the
Drosophila model of MLIV was sufficient to restore sur-
vival, motor function and synaptic transmission [21].
This fact, together with the recent finding that activated
microglia can facilitate the induction of LTP by releasing
TNF [49], further highlights the role that glial cells may
have in MLIV pathogenesis as well in other LSDs; a role
which to date has been underappreciated. The mechan-
ism by which loss of TRPML1 causes a glial response is
not clear. Recently TRPML1 was shown to be involved
in the regulation of phagocytosis in macrophages [50]
further suggesting that neuroinflammation in MLIV could
be caused by disturbed phagocytic activity in microglia. A
more detailed study of the time course and mechanisms
of neuroinflammation in Mcoln1−/− mice and primary cul-
tures of microglia and astrocytes will be in the focus of
our future work.
Very little is known about brain pathology in human
MLIV due to the lack of systematic clinical studies. An MRI
study of 15 patients with MLIV revealed a characteristic
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developmental impairment of the corpus callosum, white
matter abnormalities on T1-weighed images and depos-
ition of ferritin in basal ganglia and thalamus reflected by
the changes in the signal intensities on T1- and T2-
weighted MRIs [8]. In all but one MLIV patient with mild
clinical manifestations, the corpus callosum was uniformly
thinned, and had no rostrum together with an absent or
dysplastic splenium. The thickness of corpus callosum in
the patients with typical MLIV ranging from 16 months
to 22 years of age varied from 2 to 3 mm which corre-
sponds to the normal thickness at one month of age.
These findings have been confirmed in the recent study
recruiting five more MLIV patients of ages from 7 to
18 year-old [6]. Interestingly, we observed similar malfor-
mation of the corpus callosum with hypogenesis of the
genu and trunk and characteristic agenesis of the rostrum
and splenium in two month-old Mcoln1−/− mice. Develop-
mental defects of the corpus callosum can be caused by
impaired cell proliferation and migration, gliogenesis,
axon growth, guidance or myelination. The mechanism
resulting in dysgenic corpus callosum due to the loss of
TRPML1 remains unclear. However, our data showing
preserved cortical volume, thickness and neuron numbers
in Mcoln1−/− mice make deficits in cell proliferation or
neuron loss unlikely. Interestingly, a hypoplastic corpus
callosum and other white matter abnormalities are found
in many other LSDs: Gaucher, Krabbe, Pompe, Niemann-
Pick, NCLs, mannosidosises, gangliosidoses and mucopo-
lysaccharosidosises (reviewed in [51]). These lysosomal
diseases have an early onset in the first two years of life,
a period critical for myelination, implying the role of
aberrant lipid metabolism in oligodendrocytes in the
pathogenesis of such disorders. Our data showing early
myelination abnormalities in corpus callosum and other
white matter structures such us internal capsule and an-
terior commissure and reduced thickness of myelin
sheaths in the stratum radiatum of Mcoln1−/− mice fur-
ther support this idea.
Our electrophysiological data showing enhanced PPF
in the Schaefer collateral pathway are consistent with
the previous report of decreased synaptic transmission
in neuromuscular junctions in the Drosophila model of
MLIV, which was shown to arise from the presynaptic
impairment of synaptic vesicle cycling [21]. Notably, our
results indicated a trend toward decreased synaptic
transmission and decreased synapse density in MLIV
mice, although these differences did not reach statis-
tical significance. The significant increase in PSD
length that we observed at excitatory synapses of CA1
neurons may represent a compensatory increase in post-
synaptic active zone size in response to reduced presynaptic
input, or impaired internalization of AMPA-type glutamate
receptors. Our data also raise the possibility that reduced
myelination, the most remarkable ultrastructural finding,
may contribute to the decreased presynaptic function we
observed in MLIV mice. We suggest that the thinning of
myelin sheaths in Schaeffer collaterals may affect the effi-
ciency of glutamate release through impaired propagation
of action potentials and, thus, contribute to the develop-
ment of cognitive impairment in MLIV. Massive axonal
degeneration and formation of numerous axonal spher-
oids, which are full of aggregated mitochondria and ves-
icular electron-dense structures, has been previously
shown in cerebellar Purkinje neurons in the end stage
Mcoln1−/− mice, indicating defects in axonal transport
[26]. In contrast, we observed no such structures and no
changes in the axon caliber in Schaeffer collaterals, sug-
gesting that pathway dependent axonal pathology occurs
in these mice.
Overall, our data reveals that the glial activation is a
dramatic and early feature of MLIV, and it is not associ-
ated with overt neurodegeneration in the course of dis-
ease. This finding changes our understanding of the
disease mechanisms, shifting focus towards the role of ly-
sosomes in glial cell health and functioning, and the role
of glial dysfunction in the etiology of MLIV and other
lysosomal diseases. It also opens new frontiers in therapy
development to prevent or reverse the devastating neuro-
logic symptoms of this disease. More specifically, along
with traditional therapeutic approaches for LSDs involving
substrate reduction or gene therapy, new paradigms such
as glial progenitor cell replacement therapy or modulation
of neuroinflammation can also be considered in MLIV.
Additional files
Additional file 1: Figure S1. Brain atrophy is absent in Mcoln1−/− mice
in the course of disease. (A). Cavalieri estimates of the volume of
hippocampus, cortex, thalamus and striatum obtained from wild-type
(WT) and Mcoln1−/− (KO) littermates at two (n = 6 per genotype), three
(n (WT) = 3; n (KO) = 4) and seven months of age (n = 4 per genotype).
(B). Cortical thickness measured in the somatosensory barrelfield (S1BF),
primary motor (M1), lateral entorhinal (LEnt) and primary visual (V1) areas.
Two-way ANOVA (genotype x age) shows no significant interaction or
significant effects of genotype at any of examined brain regions.
Additional file 2: Figure S2. Iba1 staining confirms microglia activation
in Mcoln1−/− mice. Representative images of Iba1 immunostaning in
wild-type (WT) and Mcoln1−/− (KO) littermates at two months of age
showing increased immunoreactivity in KO in somatosensory barrelfield
cortex. Scale bar is equal to 150 μm. Sections were counterstained with Gill
Hematoxylin.
Additional file 3: Figure S3. Intra-glial storage in CA1 stratum radiatum
of Mcoln1−/− mice. (A). Representative electron micrograph showing
accumulation of characteristic MLIV storage bodies with electron-dense
granular and lamellar material (white arrowhead) in an astrocyte.
(B). Accumulation of clusters of lysosome-like storage inclusions in a
microglial cell or macrophage.
Additional file 4: Figure S4. Absence of neuronal loss in Mcoln1−/− mice.
Optical fractionator estimates of number of neurons in the VPL-VPM, DLG
and red nucleus of the thalamus, S1BF, and CA1 and CA3 subfields of the
hippocampus in 7 month-old wild-type (WT) and Mcoln1−/− (KO) littermates
(n = 4 per genotype). Data analyzed by t-test and show no significant
differences between WT and KO in any of the examined brain regions.
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